A detailed history of Eventide Asset Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 6,666,982 shares of ARDX stock, worth $40 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
6,666,982
Previous 6,812,968 2.14%
Holding current value
$40 Million
Previous $49.7 Million 0.67%
% of portfolio
0.87%
Previous 0.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.89 - $9.31 $859,857 - $1.36 Million
-145,986 Reduced 2.14%
6,666,982 $49.4 Million
Q1 2024

May 15, 2024

BUY
$6.05 - $9.74 $45,217 - $72,796
7,474 Added 0.11%
6,812,968 $49.7 Million
Q4 2023

Feb 14, 2024

BUY
$3.29 - $6.64 $13.5 Million - $27.3 Million
4,110,494 Added 152.52%
6,805,494 $42.2 Million
Q3 2023

Nov 14, 2023

BUY
$3.3 - $4.83 $8.89 Million - $13 Million
2,695,000 New
2,695,000 $11 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $928M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.